Regenesome Launches "SAISEI Regenesome Supplement" – A Science-Backed Agingcare Functional Food
Tokyo, Japan – Regenesome Inc. (Head Office: Minato-ku, Tokyo; CEO: Zentaro Sakuma, hereinafter “Regenesome”) is pleased to announce the development of the SAISEI Regenesome Supplement, a next-generation functional food designed for anti-aging and wellness. Full-scale sales will commence in August 2025.
Background
Regenesome has been conducting in-depth analysis of Japanese health data in collaboration with Japan System Techniques Co., Ltd., exploring scientifically backed approaches to ideal health maintenance. Since November 2024, as part of the “Fermentation and Longevity Fund” program run by its affiliated company Space Seed Holdings, the company has been strengthening partnerships with startups in fermentation technology and longevity science.
With a focus on Agingcare*, Regenesome is committed to developing products and services that support both health and beauty, contributing to the well-being of society. This new product was designed and formulated by Euglena Co., Ltd., leveraging advanced biotechnology.
*Agingcare: Age-appropriate care designed to maintain health and vitality.
Product Overview
The SAISEI Regenesome Supplement is a scientifically crafted functional food combining selected, evidence-based health ingredients with traditional wellness philosophies from Okinawa’s “Blue Zone,” integrated with modern science.
Key Ingredients:
Euglena gracilis – Contains 59 types of essential nutrients
Sake lees powder – Rich in nutrients derived from koji mold and yeast
Kalahari watermelon extract – Studied for its potential benefits on circulation and hydration
Ergothioneine – Studied for its antioxidant properties
The SAISEI Brand Concept
The SAISEI brand is built around three core values to deliver a distinctive customer experience:
(Regeneration) – Revitalizing life energy
(Prime) – Enabling one’s peak performance
(Uniqueness) – Offering products with singular value
Future Outlook
The product will be manufactured with the cooperation of Okinawa Ukondo Co., Ltd., and promoted with the support of the Butterfly Pea Research Institute. Moving forward, Regenesome will continue to develop scientifically validated food and supplement products, working with research institutions and corporate partners in Japan and abroad to deliver innovative solutions for healthy longevity.
About the Fermentation and Longevity Fund
Operated by Space Seed Holdings, the Fermentation and Longevity Fund supports early-stage projects in fermentation technology, anti-aging, and longevity science. The program targets proof-of-concept studies within 18 months, accelerating the path from research to real-world application while fostering partnerships among academia, industry, and startups.
About Regenesome Inc.
Regenesome is dedicated to developing new solutions in aging control and regenerative medicine using nanoparticles such as exosomes. In May 2025, the company opened its headquarters and research facility, the Takanawa Longevity Lab, at LiSH in Tokyo to accelerate both business and R&D. Looking ahead, Regenesome aims to create breakthrough healthcare technologies for both Earth and space, extending healthy lifespans and supporting humanity’s expansion beyond our planet.
https://regenesome.com/
